HISTAMINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Histamine, and when can generic versions of Histamine launch?
Histamine is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in HISTAMINE is histamine phosphate. There is one drug master file entry for this compound. Additional details are available on the histamine phosphate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HISTAMINE?
- What are the global sales for HISTAMINE?
- What is Average Wholesale Price for HISTAMINE?
Summary for HISTAMINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | HISTAMINE at DailyMed |
Recent Clinical Trials for HISTAMINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tanta University | PHASE2 |
| National Vulvodynia Association | PHASE2 |
| Center for Vulvovaginal Disorders | PHASE2 |
US Patents and Regulatory Information for HISTAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | HISTAMINE PHOSPHATE | histamine phosphate | INJECTABLE;INJECTION | 000734-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lilly | HISTAMINE PHOSPHATE | histamine phosphate | INJECTABLE;INJECTION | 000734-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lilly | HISTAMINE PHOSPHATE | histamine phosphate | INJECTABLE;INJECTION | 000734-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
